MARIZYME, INC.

JUPITER, FL · Founded 2007 · CIK 0001413754 · Medtech · Public

Enzyme-based coating for graft protection during coronary artery bypass surgery

marizyme.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$26M
6 Form D · May 2023
41 months since last filing
Contracts
—
No federal contracts on record
Patents
18
1 granted · 17 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$7,555,000
Private capital raisedForm D · SEC$14,554,903
Private capital raisedForm D · SEC$1,174,945
Private capital raisedForm D · SEC$1,174,945
Private capital raisedForm D · SEC$265,216
Private capital raisedForm D · SEC$1,000,000
Form D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
850Bongiovi Medical & Health Technologies, LLC—$225K
851Spartan Micro, Inc.—$1.4M
852ROM Technologies, Inc.—$7.4M
853MARIZYME, INC.—$26M
854Inogen Inc—$4.5M
855Wavefront Technology Solutions Inc.—$828K
856LOGICINK CORPORATION——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 22 related persons
  • David BarthelDirector · Executive Officer
  • Steven BrooksExecutive Officer
  • Terry BrostowinDirector
  • Amy ChandlerExecutive Officer
  • Nicholas DeVitoExecutive Officer
  • Vithalbhai DhadukDirector · Executive Officer
  • Ronald EverettExecutive Officer
  • JUAN GUTIERREZDirector · Executive Officer
  • William HearlDirector
  • Julie KampfDirector
  • George KovalyovExecutive Officer
  • Gary MacDonaldExecutive Officer
  • MARCOS NICOLAIDESExecutive Officer
  • Joerg OttDirector · Executive Officer
  • Catherine PachukExecutive Officer
  • Nilesh PatelDirector
  • Bradley RichmondExecutive Officer
  • Harrison RossExecutive Officer
  • James SapirsteinDirector · Executive Officer
  • Roger SchallerExecutive Officer
  • Michael StewartDirector
  • Donald VeryExecutive Officer

Patents

USPTO · 1 granted of 18
  • Powder Formulations And Use Thereof In Medical And/or Surgical Proceduresapplication
  • Use Of Cytoprotectant Formulations In Cell Or Tissue Transport And/or Storageapplication
  • Solutions For Increasing The Stability And Shelf Life Of An Organ And Tissue Preservation Solutionapplication
  • Solutions For Increasing The Stability And Shelf Life Of An Organ And Tissue Preservation Solutiongranted
  • Dermatological Compositions For Providing Nutrients To Skin And Methods Thereofapplication
  • Pharmaceutical Compositions And Methods For The Treatment Of Thrombosis And Delivery By Medical Devicesapplication
  • Organ And Tissue Preservation Formulations With Increased Stability And Shelf Lifeapplication
  • Solution For Preserving Vascular Conduitsapplication
  • Powder Formulations And Use Thereof In Medical And/or Surgical Proceduresapplication
  • Antioxidant-containing Eye Drop Formulations And Methods Of Prevention And/or Treatment Using Sameapplication
  • Kits And Use Thereof In Surgical Procedures For Endoscopic Harvesting Of Vesselsapplication
  • Kits And Use Thereof In Surgical Procedures For Endoscopic Harvesting Of Vesselsapplication

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.